Coacervate protocells-mediated mitochondrial transplantation restores gut epithelial energetic homeostasis in ulcerative colitis
- 1Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou City, Zhejiang Province, 325035, China
- 2School of Pharmacy, Nanchang University, Nanchang, 330006, China
- 3Research Center for Drug Safety Evaluation Hainan Medical University, Haikou, Hainan, 570216, China
Abstract
Ulcerative colitis (UC) is closely linked to mitochondrial dysfunction in intestinal epithelial cells, yet current therapies fail to correct underlying energy metabolism defects. While exogenous mitochondrial transplantation offers a promising strategy, its clinical translation is hindered by rapid loss of mitochondrial bioactivity ex vivo, poor delivery efficiency, and lysosomal degradation following cellular uptake. Here, we developed a biomimetic coacervate-based protocell system (HTP) via liquid-liquid phase separation of polyethylene glycol, tannic acid, and sodium hyaluronate for efficient encapsulation and delivery of functional mitochondria (HTP@Mito). HTP protocells preserved mitochondrial membrane potential and ATP synthesis capacity for up to 72 h in HBSS buffer at 37°C, far exceeding the viability of free mitochondria. Notably, HTP markedly enhanced intracellular delivery of isolated mitochondria via lipid-raft-mediated endocytosis. In a dextran sulfate sodium (DSS)-induced murine UC model, rectally administrating HTP@Mito achieved superior therapeutic efficacy via restoring ATP levels and mitochondrial membrane potential, scavenging reactive oxygen species (ROS). Furthermore, by reducing oxidative stress, HTP@Mito rescued lysosomal function and restored impaired autophagic flux, thereby promoting mitophagy to clear damaged mitochondria. HTP@Mito treatment also repaired intestinal epithelial tight junctions, restored goblet cell-derived mucus secretion, and rebalanced gut microbiota by increasing beneficial Lachnospiraceae while reducing pathogenic Escherichia-Shigella. Collectively, this work established a versatile, biomimetic organelle delivery platform that could correct mitochondrial energy deficiency in the intestinal epithelium, providing a framework for mitochondrial transplantation in ulcerative colitis.
Related
- Two populations with different cell dynamics maintain urethral epithelial homeostasis in female and male mice
- Notoginsenoside R1 modulates the ATF4-CHOP-Bcl2 signaling pathway to alleviate mitochondrial stress damage and apoptosis in asthmatic airway epithelial cells
- Organoid transplantation in the adult endometrium restores fertility and uncovers epithelial lineage plasticity
- NIX-associated mitochondrial remodeling contributes to esophageal epithelial differentiation
- Goblet cells mechanically breach the epithelial barrier in gut homeostasis
BibTeX
@article{ding2026coacervate,
title = {{Coacervate protocells-mediated mitochondrial transplantation restores gut epithelial energetic homeostasis in ulcerative colitis}},
author = {Bingyu Ding and Yumo Chen and Yiying Jia and Jiarui Li and Zhouyang Tan and Weilan Wu and Shenyuan Ouyang and Bingjie Tong and Lifen Wang and Helin Xu},
journal = {Bioactive materials},
year = {2026},
month = oct,
doi = {10.1016/j.bioactmat.2026.10.023},
url = {https://europepmc.org/article/PMC/PMC13717041},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Coacervate protocells-mediated mitochondrial transplantation restores gut epithelial energetic homeostasis in ulcerative colitis
AU - Bingyu Ding
AU - Yumo Chen
AU - Yiying Jia
AU - Jiarui Li
AU - Zhouyang Tan
AU - Weilan Wu
AU - Shenyuan Ouyang
AU - Bingjie Tong
AU - Lifen Wang
AU - Helin Xu
PY - 2026
DA - 2026/10/22
JO - Bioactive materials
DO - 10.1016/j.bioactmat.2026.10.023
UR - https://europepmc.org/article/PMC/PMC13717041
AB - Ulcerative colitis (UC) is closely linked to mitochondrial dysfunction in intestinal epithelial cells, yet current therapies fail to correct underlying energy metabolism defects. While exogenous mitochondrial transplantation offers a promising strategy, its clinical translation is hindered by rapid loss of mitochondrial bioactivity ex vivo, poor delivery efficiency, and lysosomal degradation following cellular uptake. Here, we developed a biomimetic coacervate-based protocell system (HTP) via liquid-liquid phase separation of polyethylene glycol, tannic acid, and sodium hyaluronate for efficient encapsulation and delivery of functional mitochondria (HTP@Mito). HTP protocells preserved mitochondrial membrane potential and ATP synthesis capacity for up to 72 h in HBSS buffer at 37°C, far exceeding the viability of free mitochondria. Notably, HTP markedly enhanced intracellular delivery of isolated mitochondria via lipid-raft-mediated endocytosis. In a dextran sulfate sodium (DSS)-induced murine UC model, rectally administrating HTP@Mito achieved superior therapeutic efficacy via restoring ATP levels and mitochondrial membrane potential, scavenging reactive oxygen species (ROS). Furthermore, by reducing oxidative stress, HTP@Mito rescued lysosomal function and restored impaired autophagic flux, thereby promoting mitophagy to clear damaged mitochondria. HTP@Mito treatment also repaired intestinal epithelial tight junctions, restored goblet cell-derived mucus secretion, and rebalanced gut microbiota by increasing beneficial Lachnospiraceae while reducing pathogenic Escherichia-Shigella. Collectively, this work established a versatile, biomimetic organelle delivery platform that could correct mitochondrial energy deficiency in the intestinal epithelium, providing a framework for mitochondrial transplantation in ulcerative colitis.
SN - 2452-199X
ER -